Evidence map›Paper›PMID 33952326›Full record

ArticleOrphanet journal of rare diseases2021

Target 5000: a standardized all-Ireland pathway for the diagnosis and management of inherited retinal degenerations.

Kirk A J Stephenson, Julia Zhu, Niamh Wynne, Adrian Dockery, Rebecca M Cairns, Emma Duignan, Laura Whelan, Conor P Malone, Hilary Dempsey, Karen Collins and 10 more

Abstract readLetter
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. History of Finding Genes and Mutations Causing Inherited Retinal Diseases.Cold Spring Harbor perspectives in medicine · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review.Investigative ophthalmology & visual science · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Case reports in ophthalmology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kirk A J StephensonMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland. kirkstephenson@hotmail.com.ORCID 0000-0002-7462-7725
Julia ZhuMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Niamh WynneThe Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Adrian DockeryOcular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Rebecca M CairnsBelfast Health and Social Care Trust Hospitals, Belfast, Northern Ireland.
Emma DuignanThe Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Laura WhelanOcular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
Conor P MaloneThe Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Hilary DempseyThe Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Karen CollinsThe Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
Shana RoutledgeMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Rajiv PandeyMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Elaine CrossanMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Jacqueline TurnerMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
James J O'ByrneMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Laura BradyFighting Blindness Ireland, Ely Place, Dublin 2, Ireland.
Giuliana SilvestriBelfast Health and Social Care Trust Hospitals, Belfast, Northern Ireland.
Paul F KennaThe Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
G Jane FarrarOcular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
David J KeeganMater Clinical Ophthalmic Genetics Unit, Mater Misericordiae University Hospital, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInherited retinal degenerations (IRD) are rare genetic disorders with > 300 known genetic loci, manifesting variably progressive visual dysfunction. IRDs were historically underserved due to lack of effective interventions. Many novel therapies will require accurate diagnosis (phenotype and genotype), thus an efficient and effective pathway for assessment and management is required.

methodsUsing surveys of existing practice patterns and advice from international experts, an all-Ireland IRD service (Target 5000) was designed. Detailed phenotyping was followed by next generation genetic sequencing in both a research and accredited laboratory. Unresolved pedigrees underwent further studies (whole gene/whole exome/whole genome sequencing). Novel variants were interrogated for pathogenicity (cascade screening, in silico analysis, functional studies). A multidisciplinary team (MDT; ophthalmologists, physicians, geneticists, genetic counsellors) reconciled phenotype with genotype. A bespoke care plan was created for each patient comprising supports, existing interventions, and novel therapies/clinical trials. RESULTS AND DISCUSSION: Prior to Target 5000, a significant cohort of patients were not engaged with healthcare/support services due to lack of effective interventions. Pathogenic or likely pathogenic variants in IRD-associated genes were detected in 62.3%, with 11.6% having variants of unknown significance. The genotyping arm of Target 5000 allowed a 42.73% cost saving over independent testing, plus the value of MDT expertise/processing. Partial funding has transferred from charitable sources to government resources.

conclusionTarget 5000 demonstrates efficacious and efficient clinical/genetic diagnosis, while discovering novel IRD-implicated genes/variants and investigating mechanisms of disease and avenues of intervention. This model could be used to develop similar IRD programmes in small/medium-sized nations.

Indexed as

Retinal DegenerationRetinal DystrophiesExomeHumansIrelandMutationPedigreeClinical diagnostic algorithmGenetic diagnosisInherited retinal degenerationsOcular geneticsPublic and patient involvementRetinal dystrophy

Identifiers

PMID33952326
PMCPMC8097252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.